Trial Profile
A phase I trial of an oncolytic virus [Panrvlysin] for pancreatic cancer.
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 13 Oct 2010
Price :
$35
*
At a glance
- Drugs Oncolytic viruses (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 13 Oct 2010 New trial record